يعرض 1 - 10 نتائج من 72 نتيجة بحث عن '"Krajsová, Ivana"', وقت الاستعلام: 1.12s تنقيح النتائج
  1. 1
  2. 2
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية

    المصدر: Ascierto, Paolo A; Dummer, Reinhard; Gogas, Helen J; Arance, Ana; Mandala, Mario; Liszkay, Gabriella; Garbe, Claus; Schadendorf, Dirk; Krajsova, Ivana; Gutzmer, Ralf; Chiarion-Sileni, Vanna; Dutriaux, Caroline; de Groot, Jan Willem B; Yamazaki, Naoya; Loquai, Carmen; Robert, Caroline; Flaherty, Keith T (2023). Contribution of MEK Inhibition to BRAF/MEK Inhibitor Combination Treatment of BRAF-Mutant Melanoma: Part 2 of the Randomized, Open-Label, Phase III COLUMBUS Trial. Journal of Clinical Oncology, 41(29):4621-4631.

    وصف الملف: application/pdf

    العلاقة: https://www.zora.uzh.ch/id/eprint/238964/7/ZORA238964.pdfTest; info:pmid/37506329; urn:issn:0732-183X

  5. 5
  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية

    المصدر: Ascierto, Paolo A; Dummer, Reinhard; Gogas, Helen J; Flaherty, Keith T; Arance, Ana; Mandala, Mario; Liszkay, Gabriella; Garbe, Claus; Schadendorf, Dirk; Krajsova, Ivana; Gutzmer, Ralf; de Groot, Jan Willem B; Loquai, Carmen; Gollerkeri, Ashwin; Pickard, Michael D; Robert, Caroline (2020). Update on tolerability and overall survival in COLUMBUS: landmark analysis of a randomised phase 3 trial of encorafenib plus binimetinib vs vemurafenib or encorafenib in patients with BRAF V600-mutant melanoma. European Journal of Cancer, 126:33-44.

    مصطلحات موضوعية: Dermatology Clinic, 610 Medicine & health

    وصف الملف: application/pdf

    العلاقة: https://www.zora.uzh.ch/id/eprint/183844/8/1-s2.0-S095980491930841X-main.pdfTest; info:pmid/31901705; urn:issn:0959-8049

  8. 8
    دورية أكاديمية

    المساهمون: Pfizer, Roche, Bristol-Myers Squibb, Merck Sharp & Dohme, Novartis, Amgen, Pierre Fabre, Amicus, Boehringer-Ingelheim, NeraCare, Philogen, Sanofi, Neracare, Array BioPharma, Boehringer Ingelheim, LEO Pharma, Hexal, InflaRx, Helsinn, GI Innovation, Immunocore, Incyte, Regeneron, 4SC, AstraZeneca, Merck-EMD, Ultimovacs, Sun Pharma, Johnson&Johnson, Merck Serono, Servier, Biontech

    المصدر: European Journal of Cancer ; volume 126, page 33-44 ; ISSN 0959-8049

    مصطلحات موضوعية: Cancer Research, Oncology

  9. 9
    دورية أكاديمية

    المصدر: Gogas, Helen J; Flaherty, Keith T; Dummer, Reinhard; Ascierto, Paolo A; Arance, Ana; Mandala, Mario; Liszkay, Gabriella; Garbe, Claus; Schadendorf, Dirk; Krajsova, Ivana; Gutzmer, Ralf; Sileni, Vanna Chiarion; Dutriaux, Caroline; de Groot, Jan Willem B; Yamazaki, Naoya; Loquai, Carmen; Gollerkeri, Ashwin; Pickard, Michael D; Robert, Caroline (2019). Adverse events associated with encorafenib plus binimetinib in the COLUMBUS study: incidence, course and management. European Journal of Cancer, 119:97-106.

    مصطلحات موضوعية: Dermatology Clinic, 610 Medicine & health

    وصف الملف: application/pdf

  10. 10
    دورية أكاديمية